Strategic Meeting during this week between the Shareholders of Probiomed (Mexico) and AXXO in order to discuss our future strategy regarding the development and distribution of our Biotechnology Portfolio – with the focus especially on the Monoclonal Antibody Products. The fundament of our company is built on trust and on the experience of a dynamic, multi-disciplinary and highly qualified team. The application of a unified work methodology, with a focus on quality in everything we do. Thank you for such a great visit in Hamburg at the AXXO Headquarter.
https://www.axxo.de/wp-content/uploads/2019/03/AXXO-Transparent-gut-300x134.png 0 0 adminr0u1at42 https://www.axxo.de/wp-content/uploads/2019/03/AXXO-Transparent-gut-300x134.png adminr0u1at422019-05-29 11:07:252019-05-29 11:13:46Strategic Meeting during this week between....
Firmenname: AXXO Im- und Export GmbH
Geschäftsführer: Frank Nedder
Umsatzsteuer-ID-Nummer: DE 812 19 2621